0000950170-24-026658.txt : 20240305 0000950170-24-026658.hdr.sgml : 20240305 20240305201900 ACCESSION NUMBER: 0000950170-24-026658 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240303 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lyons Dillon JoEllen CENTRAL INDEX KEY: 0001570168 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39695 FILM NUMBER: 24723907 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE STREET 2: MOSQUITO WAY CITY: HATFIELD, HARTFORDSHIRE STATE: X0 ZIP: AL 109UL ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viatris Inc CENTRAL INDEX KEY: 0001792044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834364296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: (724) 514-1465 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: Upjohn Inc DATE OF NAME CHANGE: 20191023 4 1 ownership.xml 4 X0508 4 2024-03-03 0001792044 Viatris Inc VTRS 0001570168 Lyons Dillon JoEllen 1000 MYLAN BOULEVARD CANONSBURG PA 15317 true false false false true Common Stock 2024-03-03 4 M false 17970 0.00 A 77829 D Common Stock 2024-03-03 4 M false 885 0.00 A 78714 D Common Stock 2024-03-05 4 S false 20000 12.36 D 58714 D Common Stock 18 I By Spouse Restricted Stock Units 0.00 2024-03-03 4 M false 17970 0.00 D Common Stock 17970 0 D Dividend Equivalent Units 0.00 2024-03-03 4 M false 884.8005 0.00 D Common Stock 884.8005 0 D Restricted Stock Units 0.00 2024-03-04 4 A false 18204 0.00 A Common Stock 18204 18204 D Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on November 28, 2023. Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 3, 2024. Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. /s/ Kevin Macikowski, by power of attorney 2024-03-05